Our top pick for
Akerna Corp is a health information services business based in the US. Akerna shares (KERN) are listed on the NASDAQ and all prices are listed in US Dollars. Akerna employs 144 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$3.09|
|52-week range||$2.28 - $10.44|
|50-day moving average||$3.05|
|200-day moving average||$3.72|
|Wall St. target price||$7.83|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.72|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-13)||5.10%|
|1 month (2021-09-20)||8.80%|
|3 months (2021-07-20)||-14.88%|
|6 months (2021-04-20)||-18.47%|
|1 year (2020-10-20)||-16.94%|
|2 years (2019-10-18)||-45.31%|
|3 years (2018-10-19)||10.16|
|5 years (2016-10-16)||N/A|
|Revenue TTM||$18.5 million|
|Gross profit TTM||$9.4 million|
|Return on assets TTM||-25.75%|
|Return on equity TTM||-70.95%|
|Market capitalisation||$88.4 million|
TTM: trailing 12 months
There are currently 1.9 million Akerna shares held short by investors – that's known as Akerna's "short interest". This figure is 16.4% down from 2.3 million last month.
There are a few different ways that this level of interest in shorting Akerna shares can be evaluated.
Akerna's "short interest ratio" (SIR) is the quantity of Akerna shares currently shorted divided by the average quantity of Akerna shares traded daily (recently around 965774.3718593). Akerna's SIR currently stands at 1.99. In other words for every 100,000 Akerna shares traded daily on the market, roughly 1990 shares are currently held short.
However Akerna's short interest can also be evaluated against the total number of Akerna shares, or, against the total number of tradable Akerna shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Akerna's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Akerna shares in existence, roughly 70 shares are currently held short) or 0.0915% of the tradable shares (for every 100,000 tradable Akerna shares, roughly 92 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Akerna.
Find out more about how you can short Akerna stock.
We're not expecting Akerna to pay a dividend over the next 12 months.
Over the last 12 months, Akerna's shares have ranged in value from as little as $2.28 up to $10.438. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Akerna's is 3.0417. This would suggest that Akerna's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Akerna Corp. provides enterprise software solutions that enable regulatory compliance and inventory management in United States and Canada. The company offers MJ Platform, an enterprise resource planning compliance system to the cannabis industry, including state-legal marijuana, hemp, and CBD industry; and Leaf Data Systems, a compliance tracking system designed for government agencies. It also provides consulting services to cannabis industry; business intelligence, an infrastructure as a service tool, which delivers supply chain analytics for the cannabis, hemp, and CBD industries; and Last Call Analytics, a subscription analytics tool for alcohol brands to analyze their retail sales analytics. In addition, the company operates seed-to-sale platform that allows cultivators to track and report various stage of their cannabis growing operations, production, and sales processes. Further, it offers cannabis cultivation management and software to manage and optimize operational workflow in business analytics; and cannabis tracking technology that provides seed-to-sale-to-self data. Akerna Corp.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.